Cunard Celebrates Record Bookings Following Queen Anne Launch
The 3,000-guest vessel set sail on an historic maiden voyage on
The luxury cruise brand can now report it booked more guests in May than any equivalent period on record, with Queen Anne Europe itineraries proving to be particularly popular with guests.
Culture
Cunard President
For more information about Cunard or to book a voyage, contact your Travel Advisor, call Cunard at 1-800-728-6273, or visit www.cunard.com.
For Travel Advisors interested in further information, please contact your Business Development Manager, visit OneSourceCruises.com, or call Cunard at 1-800-528-6273.
ABOUT CUNARD:
Cunard is a luxury British cruise line, renowned for creating unforgettable experiences around the world. Cunard has been a leading operator of passenger ships since 1840, celebrating an incredible 184 years of operation. The Cunard experience is built on fine dining, hand-selected entertainment, and outstanding White Star service. From a partnership with a two-Michelin starred chef, to inspiring guest speakers, to world class theatre productions, every detail has been meticulously crafted to make the experience unforgettable. A pioneer in transatlantic journeys and round world voyages, destinations sailed to also include
There are currently four Cunard ships, Queen Mary 2,
Social Media
Facebook: www.facebook.com/cunard
Twitter: www.twitter.com/cunardline
YouTube: www.youtube.com/wearecunard
Instagram: www.instagram.com/cunardline
For additional information about Cunard, contact:
Cindy Adams, [email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/cunard-celebrates-record-bookings-following-queen-anne-launch-302169986.html
SOURCE Cunard
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Project Pigeon Consortium Launches APAC Working Group to Advance Governance Standards for Permissionless Blockchains
- Samsonite Group S.A. to Acquire BÉIS, Expanding its Lifestyle Portfolio and Enhancing Digital Capabilities
- ArkBio Announces China IND Approval for its Antiviral Drug-Fc Conjugate (AFC) Candidate AK0406 for Influenza Prophylaxis
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share